(Q26826906)

S.-s. Park

2

1 reference

E. Kim

3

1 reference

Y. Sook Yoon

4

1 reference

C.-Y. Park

6

1 reference

Y. Ho Yun

7

1 reference

S. Woo Oh

8

1 reference

language of work or name

1 reference

August 2013

1 reference

International Journal of Epidemiology

published in

1 reference

volume

42

1 reference

issue

4

1 reference

page(s)

1029-39

1 reference

Adipokines as novel biomarkers and regulators of the metabolic syndrome

cites work

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Adiponectin action from head to toe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Mechanisms of adiponectin regulation and use as a pharmacological target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Adiponectin and mortality in patients undergoing coronary angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Association of serum adiponectin with risk for cardiovascular events in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Adiponectin and risk of coronary heart disease in older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Plasma adiponectin level and myocardial infarction: the JMS Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Adiponectin resistance and vascular dysfunction in the hyperlipidemic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Adiponectin and Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Circulating Adiponectin Levels and Mortality in Elderly Men With and Without Cardiovascular Disease and Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Prognostic Value of Adiponectin for Cardiovascular Disease and Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Adiponectin and Renal Function, and Implication as a Risk of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

7 January 2021

Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

7 January 2021

Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

7 January 2021

High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association?

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

7 January 2021

Adiponectin and Coronary Heart Disease: The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYT087

7 January 2021